This is a preview of subscription content, log in via an institution to check access.
REFERENCE
sanofi-aventis.Sanofi Aventis: New Real Life Studies Illustrate Greater A1C Lowering and Cost Benefit Observed With LANTUS(R) Over Detemir and NPH Insulin. Media Release: 8 Sep 2008. Available from: URL: http://www.sanofi-aventis.com
Rights and permissions
About this article
Cite this article
Insulin glargine shows its value in type 2 diabetes mellitus. Pharmacoecon. Outcomes News 562, 4 (2008). https://doi.org/10.2165/00151234-200805620-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805620-00008